X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Quarterly Results   (LUPL)

Here are the latest quarterly results of Lupin Ltd. For more details, see the Lupin Ltd financial fact sheet and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-17
*
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
*
3
Dec-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m42,53324,99325,80025,31324,77625,79139,51145,049 
Other income Rs m4532797432405321,7252,307434 
Turnover Rs m42,98625,27226,54325,55225,30827,51641,81745,483 
Expenses Rs m35,12619,55920,38520,33120,23220,77834,01437,523 
Gross profit Rs m7,8135,4345,4154,9824,5455,0145,4964,103 
Depreciation Rs m2,6749519549921,0021,0452,6552,798 
Interest Rs m40662106679672738798 
Profit before tax Rs m5,1864,7005,0984,1623,9795,6224,410942 
Tax Rs m1,3671,1591,2091,0701,0541,3271,7292,478 
Profit after tax Rs m3,8193,5413,8893,0922,9254,2952,681-1,536 
Gross profit margin %18.421.721.019.718.319.413.99.1 
Effective tax rate %26.424.723.725.726.523.639.2263.0 
Net profit margin %9.014.215.112.211.816.76.8-3.4 
Diluted EPS Rs 8.5 7.8 8.6 6.9 6.5 9.5 5.9 -3.4  
Diluted EPS (TTM) Rs 56.7 45.0 39.0 31.8 29.8 31.5 28.8 18.5  
 Subscriber Feature View View View View          
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Lupin Ltd 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare LUPIN With:   BIOCON   ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 135 Points Lower; Realty and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Views on news

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

A 90% Chance of Auto Stocks Moving Up This April(Profit Hunter)

Apr 5, 2019

The Auto index ended on a positive note in the month of April in 9 out of last 10 years. This Auto stock is best placed to benefit from the upswing in this sector.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Apr 18, 2019 03:37 PM

TRACK LUPIN

LUPIN - FRESENIUS KABI ONCO. COMPARISON

COMPARE LUPIN WITH

MARKET STATS